12-03-2023, 04:01

HAGENS BERMAN, NATIONAL TRIAL ATTORNEYS, Encourages Y-mAbs

SAN FRANCISCO, March 11, 2023 (GLOBE NEWSWIRE) -- Hagens Berman urges Y-mAbs Therapeutics, Inc. (NASDAQ: YMAB)
Globe Newswire12-03-2023, 04:01
3-02-2023, 07:42

HAGENS BERMAN, NATIONAL TRIAL ATTORNEYS, Encourages Evolv

SAN FRANCISCO, Feb. 02, 2023 (GLOBE NEWSWIRE) -- Hagens Berman is investigating possible misrepresentations concerning
Globe Newswire3-02-2023, 07:42